Successful Pregnancy and Delivery After Frozen-thawed Embryo Transfer Following the Third Discontinuation of Tyrosine Kinase Inhibitor in a Woman with Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Successful Pregnancy and Delivery After Frozen-thawed Embryo Transfer Following the Third Discontinuation of Tyrosine Kinase Inhibitor in a Woman with Chronic Myeloid Leukemia

Published:2024 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Takayama Kosuke¹,Fujisawa Shin¹,Sakuma Takayuki¹,Hasegawa Kodai¹,Katsuki Kengo¹,Akimoto Masahiro¹,Matsumura Ayako¹,Nakajima Yuki¹,Miyazaki Takuya¹,Murase Mariko²,Nakajima Hideaki³

Affiliation:

1. Department of Hematology, Yokohama City University Medical Center, Japan

2. Reproductive Medicine Center, Yokohama City University Medical Center, Japan

3. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3322-23/_pdf

Reference18 articles.

1. 1. Hasford J, Pfirrmann M, Hochhaus A. How long will chronic myeloid leukemia patients treated with imatinib mesylate live?. Leukemia 19: 497-499, 2005.

2. 2. Sasaki K, Strom SS, O'Brien S, et al. Relative survival in patients with chronic-phase chronic myeloid leukemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol 2: e186-93-e193, 2015.

3. 3. Hoffmann VS, Baccarani M, Hasford J, et al. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European countries. Leukemia 29: 1336-1343, 2015.

4. 4. Furukawa Y, Takahashi T, Suganuma R, et al. Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: case report and literature review. Mediterr J Hematol Infect Dis 12: e2020005, 2020.

5. 5. Legros L, Nicolini FE, Etienne G, et al. Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia. Cancer 123: 4403-4410, 2017.